National Taiwan University Hospital (NTUH), in collaboration with multiple medical centers across Taiwan, has found that patients with hepatitis C remain at a significantly elevated risk of ...
In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook. When facing liver cancer, patients often rely ...
A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the clearest roadmaps to date for understanding and treating liver cancer, one of the ...
Post-Whipple endocrine and gastrointestinal complications created ongoing needs around glycemic control, nutrition tolerance, and medication routines rather than a finite “recovery” endpoint.
RAMAT GAN, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs ...
A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results